Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Sapience Therapeutics
AddedFeb 15, 2024
UpdatedJul 17, 2026
Sapience Therapeutics

Sapience Therapeutics

Seed

Sapience Therapeutics: A NY-based biotech firm providing innovative therapies for critical medical needs.

HQ
Harrison, NY, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Sapience Therapeutics is a biotechnology company focused on developing innovative therapies for critical medical needs, particularly targeting mortality cancers. Based in New York, the company pioneers first-in-class peptide antagonists known as SPEARs™ (Stabilized Peptides Engineered Against Resistance) to address elusive oncogenic and immune-modulating drug targets. Sapience Therapeutics aims to provide new treatment options for cancer patients by tackling the disease at its source.

Sapience Therapeutics has made significant strides in the biotechnology sector, advancing its clinical trials and expanding its therapeutic pipeline. The company's approach has garnered attention for its potential to overcome persistent hurdles in oncology, offering hope to patients with limited treatment options. Through its innovative research and development, Sapience Therapeutics continues to impact the field of cancer treatment positively.

Sapience Therapeutics - Similar Companies

Saphtx logo

Saphtx

Seneca Therapeutics logo

Seneca Therapeutics

SphynKx Therapeutics logo

SphynKx Therapeutics

Scorpion Therapeutics logo

Scorpion Therapeutics

Dialectic Therapeutics logo

Dialectic Therapeutics

dtsciences.com

Sapir Pharmaceuticals logo

Sapir Pharmaceuticals

PineTree Therapeutics logo

PineTree Therapeutics

pinetreetx.com

Meditope Biosciences logo

Meditope Biosciences

meditope.com

Spheringenics logo

Spheringenics

Palm Therapeutics logo

Palm Therapeutics

Sapient logo

Sapient

sapient.bio

Sarentis Therapeutics logo

Sarentis Therapeutics

Telo Therapeutics logo

Telo Therapeutics

Soteria Biotherapeutics logo

Soteria Biotherapeutics

Alphina Therapeutics logo

Alphina Therapeutics

Sapience Therapeutics - Quick Facts

Who are Sapience Therapeutics' competitors?

Companies similar to Sapience Therapeutics include Saphtx, Seneca Therapeutics, SphynKx Therapeutics and Scorpion Therapeutics.

When was Sapience Therapeutics founded?

Sapience Therapeutics was founded in 2015.

Where is Sapience Therapeutics' headquarters located?

Sapience Therapeutics' headquarters is located in Harrison, NY, US.

When was Sapience Therapeutics' last funding round?

Sapience Therapeutics' most recent funding round was for $2M (USD) in May 2023.

How much has Sapience Therapeutics raised to-date?

As of May 4, 2023, Sapience Therapeutics has raised a total of $73.5M (USD).

How many employees does Sapience Therapeutics have?

Sapience Therapeutics has 18 employees as of Feb 5, 2024.

Sapience Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatment
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified